Menu
From July, Australia has authorised psychedelics to prescribe PSILOCYBIN (the active chemical in magic mushrooms) for treatment – resistant depression and MDMA for PTSD.
Research & Development amounts of these psychotropic medicines will be delivered back into pharmaceutical companies to further understand the mental health issues of today and tomorrow and how these medicines can be adapted to better serve the needs of the people.
Utilising existing psychotropic drugs such as MDMA, Mynd Biotech works in conjunction with its partners to manufacture and distribute next generation medicine ranges further to their research & development.
At Mynd Biotech, we are committed to advancing the understanding and treatment of mental health issues. Through our research and development of psychotropic medicines, we aim to provide innovative solutions that improve the lives of those affected by mental health conditions. Our goal is to contribute to a world where mental health is prioritized, and everyone has access to the care and support they need.
Remember, mental health can affect us all, directly or indirectly. By working together and supporting each other, we can create a healthier, more understanding society.
56 STEEL STREET NORTH MELBOURNE VICTORIA AUSTRALIA 3051
56 STEEL STREET NORTH MELBOURNE VICTORIA AUSTRALIA 3051
chris@myndbiotech.com
bruce@myndbiotech.com